Aethlon Medical Announces Second HIV/AIDS Treatment Site Aethlon Medical, Inc. (OTCBB:AEMD) announced today that it has added a second HIV/AIDS clinical study location at the Bhvani Hospital in Bihar, India. Aethlon previously disclosed plans to initiate the "first-in-man" clinical study of a medical device to treat the Human Immunodeficiency Virus (HIV), which causes Acquired Immune Deficiency Syndrome (AIDS).
Source: www.medicalnewstoday.comCirculating Tumor Cells Can Reveal Genetic Signature Of Dangerous Lung Cancers Massachusetts General Hospital (MGH) investigators have shown that an MGH-developed, microchip-based device that detects and analyzes tumor cells in the bloodstream can be used to determine the genetic signature of lung tumors, allowing identification of those appropriate for targeted treatment and monitoring genetic changes that occur during therapy.
Source: www.medicalnewstoday.com
# posted by Network @ 1:00 PM
